Advertisement
Table 2 Outcomes per cohort of 1000 critically ill patients with suspected nosocomial candidemia
| Outcome | Point estimate | 95% confidence interval* |
|---|---|---|
| Empiric MIC compared with empiric FLU | ||
| Deaths averted | 4 | 2 to 13 |
| Incremental cost/death averted† | $61,446 | $43,821 to $80,039 |
| Incremental cost/life year saved†¶ | $22,230 | $18,201 to $26,088 |
| Incremental cost/QALY†¶ | $34,734 | $26,312 to $49,209 |
| Empiric MIC compared with watchful waiting strategy | ||
| Deaths averted | 29 | 11 to 69 |
| Incremental cost/death averted† | $9,892 | $3,771 to $26,065 |
| Incremental cost/life year saved†¶ | $17,777 | $14,174 to $21,360 |
| Incremental cost/QALY†¶ | $27,777 | $20,572 to $39,888 |
| Empiric FLU compared with watchful waiting strategy | ||
| Deaths averted | 25 | 9 to 57 |
| Incremental cost/death averted† | $1,704 | $640 to $4,839 |
| Incremental cost/life year saved†¶ | $17,070 | $13,582 to $20,436 |
| Incremental cost/QALY†¶ | $26,672 | $19,699 to $38,223 |
